Search

Your search keyword '"BRESCIA MORRA, V"' showing total 476 results

Search Constraints

Start Over You searched for: Author "BRESCIA MORRA, V" Remove constraint Author: "BRESCIA MORRA, V"
476 results on '"BRESCIA MORRA, V"'

Search Results

1. Sexual dysfunction in multiple sclerosis: the impact of different MSISQ-19 cut-offs on prevalence and associated risk factors

4. Clinical validation in multiple sclerosis of the lumipulse immunoassay for plasma neurofilament light chain

6. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

7. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

9. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

10. MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis

11. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

13. Signs and symptoms of COVID-19 in patients with multiple sclerosis

15. Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential

16. Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis

17. JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level

18. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

19. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

20. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

21. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

22. Signs and symptoms of COVID-19 in patients with multiple sclerosis

23. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

27. The Italian multiple sclerosis register

28. Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis

30. A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis

32. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

33. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

39. Retinal vascular density in multiple sclerosis: a one year follow up

43. Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis

46. Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study

50. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis

Catalog

Books, media, physical & digital resources